MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
158 hedge funds and large institutions have $1.05B invested in Momenta Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 38 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
3.53%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
72
Reduced
38
Closed
34
Calls
$771K
Puts
$280K
Net Calls
+$491K
Net Calls Change
-$891K
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$39.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$33.4M |
| 3 |
PA
Perceptive Advisors
New York
|
+$30.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.4M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$43.2M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$28.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$20.8M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$10.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$10M |
